View in EDS HTML Full Text PDF Full Text

Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.

Saved in:
Bibliographic Details
Title: Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.
Authors: Charrez B; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Charwat V; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Siemons BA; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Goswami I; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States., Sakolish C; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States., Luo YS; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States., Finsberg H; Simula Research Laboratory, Oslo, Norway., Edwards AG; Department of Pharmacology, School of Medicine, University of California at Davis, Davis, CA, United States., Miller EW; Department of Chemistry, University of California at Berkeley, Berkeley, CA, United States.; Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, United States.; Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, CA, United States., Rusyn I; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States., Healy KE; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.; Department of Materials Science and Engineering, University of California at Berkeley, Berkeley, CA, United States.
Source: Frontiers in pharmacology [Front Pharmacol] 2021 Aug 04; Vol. 12, pp. 684252. Date of Electronic Publication: 2021 Aug 04 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34421592
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Charrez+B%22">Charrez B</searchLink>; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.<br /><searchLink fieldCode="AU" term="%22Charwat+V%22">Charwat V</searchLink>; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.<br /><searchLink fieldCode="AU" term="%22Siemons+BA%22">Siemons BA</searchLink>; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.<br /><searchLink fieldCode="AU" term="%22Goswami+I%22">Goswami I</searchLink>; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.<br /><searchLink fieldCode="AU" term="%22Sakolish+C%22">Sakolish C</searchLink>; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States.<br /><searchLink fieldCode="AU" term="%22Luo+YS%22">Luo YS</searchLink>; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States.<br /><searchLink fieldCode="AU" term="%22Finsberg+H%22">Finsberg H</searchLink>; Simula Research Laboratory, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Edwards+AG%22">Edwards AG</searchLink>; Department of Pharmacology, School of Medicine, University of California at Davis, Davis, CA, United States.<br /><searchLink fieldCode="AU" term="%22Miller+EW%22">Miller EW</searchLink>; Department of Chemistry, University of California at Berkeley, Berkeley, CA, United States.; Department of Molecular and Cell Biology, University of California at Berkeley, Berkeley, CA, United States.; Helen Wills Neuroscience Institute, University of California at Berkeley, Berkeley, CA, United States.<br /><searchLink fieldCode="AU" term="%22Rusyn+I%22">Rusyn I</searchLink>; Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, United States.<br /><searchLink fieldCode="AU" term="%22Healy+KE%22">Healy KE</searchLink>; Department of Bioengineering and California Institute for Quantitative Biosciences (QB3), University of California at Berkeley, Berkeley, CA, United States.; Department of Materials Science and Engineering, University of California at Berkeley, Berkeley, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2021 Aug 04; Vol. 12, pp. 684252. <i>Date of Electronic Publication: </i>2021 Aug 04 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34421592
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2021.684252
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 684252
    Titles:
      – TitleFull: Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Charrez B
      – PersonEntity:
          Name:
            NameFull: Charwat V
      – PersonEntity:
          Name:
            NameFull: Siemons BA
      – PersonEntity:
          Name:
            NameFull: Goswami I
      – PersonEntity:
          Name:
            NameFull: Sakolish C
      – PersonEntity:
          Name:
            NameFull: Luo YS
      – PersonEntity:
          Name:
            NameFull: Finsberg H
      – PersonEntity:
          Name:
            NameFull: Edwards AG
      – PersonEntity:
          Name:
            NameFull: Miller EW
      – PersonEntity:
          Name:
            NameFull: Rusyn I
      – PersonEntity:
          Name:
            NameFull: Healy KE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 08
              Text: 2021 Aug 04
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1